5-methoxytryptamine has been researched along with Carcinoma, Ehrlich Tumor in 2 studies
5-Methoxytryptamine: Serotonin derivative proposed as potentiator for hypnotics and sedatives.
5-methoxytryptamine : A member of the class of tryptamines that is the methyl ether derivative of serotonin.
Carcinoma, Ehrlich Tumor: A transplantable, poorly differentiated malignant tumor which appeared originally as a spontaneous breast carcinoma in a mouse. It grows in both solid and ascitic forms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kozin, SV | 2 |
| Sevast'ianov, AI | 1 |
| Iarmonenko, SP | 1 |
| Voloshina, EA | 1 |
2 other studies available for 5-methoxytryptamine and Carcinoma, Ehrlich Tumor
| Article | Year |
|---|---|
[Experimental evaluation of the role of blood flow inhibition in hyperglycemia-enhanced radiation damage to tumors].
Topics: 5-Methoxytryptamine; Animals; Blood Glucose; Carcinoma, Ehrlich Tumor; Combined Modality Therapy; Ma | 1986 |
[Postradiation impairment of tumor blood supply using polyradiomodification for increasing the effectiveness of radiotherapy].
Topics: 5-Methoxytryptamine; Animals; Blood Glucose; Carcinoma, Ehrlich Tumor; Combined Modality Therapy; Co | 1986 |